Mark G. Edwards, Director at ACELRX PHARMACEUTICALS INC (ACRX), bought 20,700 shares at $2.82 ($58K) on 2018-11-15, disclosed to the SEC on 2018-11-15.
Open-market purchase of $58k ACRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ACRX | BUY | 2019-03-12 | $114K | — | Filing → |
| ACRX | BUY | 2018-08-08 | $15K | — | Filing → |
| ACRX | BUY | 2018-06-05 | $17K | — | Filing → |